Peter Hellemans
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmacogenetics and Drug Metabolism 9
- Genetics 7
- Chronic Lymphocytic Leukemia Research 7
- Co-authors
- Johan Willem Smit (4 shared papers)A.T. van Oosterom (3 shared papers)P. Buytaert (2 shared papers)Jan Gerris (4 shared papers)Juthamas Sukbuntherng (10 shared papers)Ronald de Vries (4 shared papers)Eric Van Marck (1 shared paper)Joost Weyler (1 shared paper)
- Journals
- Blood (6 papers)Cancer Chemotherapy and Pharmacology (4 papers)Clinical Cancer Research (3 papers)European Journal of Obstetrics & Gynecology and Reproductive Biology (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- BelgiumUnited StatesSpain
In The Last Decade
Peter Hellemans
40 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 73
- Genetics 192
- Pharmacology 171
- Pathology and Forensic Medicine 210
- Hematology 131
- Cancer Research 111
Countries citing papers authored by Peter Hellemans
This map shows the geographic impact of Peter Hellemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hellemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hellemans more than expected).
Fields of papers citing papers by Peter Hellemans
This network shows the impact of papers produced by Peter Hellemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hellemans. The network helps show where Peter Hellemans may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hellemans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 226 | |
| 2 | 1995 | 171 | |
| 3 | 2013 | 107 | |
| 4 | 2019 | 91 | |
| 5 | 2015 | 90 | |
| 6 | 2015 | 72 | |
| 7 | 2015 | 66 | |
| 8 | 2015 | 65 | |
| 9 | 1995 | 61 | |
| 10 | 2016 | 54 | |
| 11 | 2020 | 43 | |
| 12 | 2018 | 38 | |
| 13 | 1991 | 35 | |
| 14 | 1995 | 29 | |
| 15 | 2020 | 29 | |
| 16 | 2016 | 27 | |
| 17 | 2017 | 26 | |
| 18 | 2016 | 24 | |
| 19 | 2018 | 24 | |
| 20 | 2022 | 22 |
About Peter Hellemans
Peter Hellemans is a scholar working on Pharmacology, Genetics, Hematology, Pulmonary and Respiratory Medicine and Oncology, having authored 40 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Multiple Myeloma Research and Treatments (6 papers), Lung Cancer Treatments and Mutations (3 papers), Prostate Cancer Treatment and Research (3 papers), Cutaneous lymphoproliferative disorders research (2 papers), Preterm Birth and Chorioamnionitis (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). The work is most often cited by research in Genetics (192 citations), Pharmacology (171 citations), Pathology and Forensic Medicine (210 citations), Hematology (131 citations) and Cancer Research (111 citations). Peter Hellemans has collaborated with scholars based in Belgium, United States and Spain. Frequent co-authors include Johan Willem Smit, A.T. van Oosterom, P. Buytaert, Jan Gerris, Juthamas Sukbuntherng, Ronald de Vries, Eric Van Marck, Joost Weyler, Nele Fourneau and James Juhui Jiao. Their work appears in journals such as Blood, Cancer Chemotherapy and Pharmacology, Clinical Cancer Research, European Journal of Obstetrics & Gynecology and Reproductive Biology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.